CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on December 11, 2019
December 11, 2019
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
| Re: | AETHLON MEDICAL, INC. | |
| Registration Statement on Form S-1 (Registration No. 333-234712) | ||
| Concurrence in Acceleration Request |
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (“Wainwright”), as managing underwriter for the above-referenced offering, hereby concurs in the request by Aethlon Medical, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. Eastern Time on Thursday, December 12, 2019, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.
| Very truly yours, | |
| H.C. WAINWRIGHT & CO., LLC | |
| By: /s/ Edward D. Silvera | |
| Name: Edward D. Silvera | |
| Title: Chief Operating Officer | |